---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-001060"
form_type: "8-K"
ticker: "IBO"
cik: "0001834105"
company_name: "IMPACT BIOMEDICAL INC."
filed_at: "2025-03-28T23:59:59+00:00"
generated_at: "2026-05-24T03:16:03.407908+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Impact Biomedical settles $8.7M debt with 2.4M shares at $3.60/share

## Summary
- Debt conversion with DSS Inc. settles $8,697,142.80 of the $13,176,477.03 principal balance.
- Issued 2,415,873 shares of common stock at $3.60 per share, equal to March 24 closing price.
- Original promissory note principal was $12,000,000; amended September 16, 2024.
- Settlement reduces outstanding debt by 66% while diluting existing shareholders by approximately 2.4M shares.

## SEC filing metadata
- accession: 0001641172-25-001060
- form_type: 8-K
- ticker: IBO
- cik: 0001834105
- company_name: IMPACT BIOMEDICAL INC.
- filed_at: 2025-03-28T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1834105/000164117225001060/0001641172-25-001060-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1834105/000164117225001060/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-001060
- JSON: https://secwatch.observer/filing/0001641172-25-001060.json
- Plain text: https://secwatch.observer/filing/0001641172-25-001060.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.